NCT01310972已完成不适用
Adjuvant Colon Cancer With ELOXatin®/5 FU Based Regimen: ACCELOX
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 6
- 试验地点
- 1
- 主要终点
- OS, PFS, DFS
研究概览
简要总结
Adjuvant Colon Cancer With ELOXatin®/5 FU Based Regimen: ACCELOX
详细描述
It's a study of adjuvant colon carcinoma using ELOXatin/5-FU based chemotherapeutic regimen called ACCELOX as a definitive curative therapy.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 14 Years 至 85 Years（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with Adjuvant Colon Cancer
排除标准
- •Patients with diagnosis other than Colon Cancer.
结局指标
主要结局
OS, PFS, DFS
时间窗: For the duration of the experiment
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
3 期
MOSAIC - Multicenter International Study of Oxaliplatin/ 5FU-LV in the Adjuvant Treatment of Colon CancerColonic NeoplasmsNCT00275210Sanofi2,246
尚未招募
3 期
Adjuvant mFOLFOXIRI vs. mFOLFOX6 in MRD Positive Stage II-III Colorectal Cancer (AFFORD)Colorectal CancerNCT05427669Yanhong Deng340
招募中
2 期
Fluorouracil Treatment Via Colon for Colorectal CancerColorectal CancerNCT06385418The Second Hospital of Nanjing Medical University40
招募中
3 期
Neoadjuvant FOLFOXIRI Versus Immediate Surgery for Stage II and III Colon CancersColon Cancer Stage IIColon Cancer Stage IIINCT05194878Sun Yat-sen University840
进行中（未招募）
2 期
PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing SurgeryColorectal CancerNCT01515787Alliance for Clinical Trials in Oncology1,194